From the Centers for Disease Control and Prevention. Considerations for distinguishing influenza-like illness from inhalational anthrax.
D000881:Anthrax / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D001408:Bacillus anthracis / Q000302:isolation & purification; D019411:Clinical Laboratory Techniques; D003937:Diagnosis, Differential; D006801:Humans; D007251:Influenza, Human / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D009975:Orthomyxoviridae / Q000302:isolation & purification; D012136:Respiratory Syncytial Viruses / Q000302:isolation & purification; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology* / Q000503:physiopathology; D014481:United States / Q000453:epidemiology